Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo

ClinicalTrials.gov ID: NCT02192554

Public ClinicalTrials.gov record NCT02192554. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 9:07 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To follow-up on the safety of subjects who were previously treated in a double-blind trial of brexpiprazole.

Study identification

NCT ID
NCT02192554
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Enrollment
450 participants

Conditions and interventions

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2014 (Actual)
Primary completion
May 2017 (Actual)
Completion
May 2017 (Actual)
Last update posted
Apr 30, 2018

2014 – 2017

United States locations

U.S. sites
28
U.S. states
11
U.S. cities
24
Facility City State ZIP Site status
Not listed Tuscaloosa Alabama 35404 —
Not listed Costa Mesa California 92626 —
Not listed Lakewood California 90805 —
Not listed Orange California 92868 —
Not listed Redlands California 92373 —
Not listed Bradenton Florida 34205 —
Not listed Hialeah Florida 33012 —
Not listed Hialeah Florida 33018 —
Not listed Miami Florida 33122 —
Not listed Miami Florida 33126 —
Not listed Miami Florida 33137 —
Not listed Miami Florida 33175 —
Not listed Miami Springs Florida 33166 —
Not listed North Miami Florida 33161 —
Not listed Orange City Florida 32763 —
Not listed Sarasota Florida 34239 —
Not listed Atlanta Georgia 30331 —
Not listed Suwanee Georgia 30024 —
Not listed Quincy Massachusetts 02169 —
Not listed St Louis Missouri 63128 —
Not listed Toms River New Jersey 08755 —
Not listed Brooklyn New York 11214 —
Not listed New Hyde Park New York 11040 —
Not listed Charlotte North Carolina 28270 —
Not listed Hickory North Carolina 28601 —
Not listed Raleigh North Carolina 27609 —
Not listed Dallas Texas 75243 —
Not listed Waukesha Wisconsin 53188 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 56 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02192554, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 30, 2018 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02192554 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →